The Fred & Pamela Buffett Cancer Center – Kearney is set to open in December 2024. It is a 53,000-square-foot facility that will offer comprehensive cancer care to patients in central Nebraska.
Thanks to cancer researchers' hard work and dedication, dramatic improvements across the spectrum of cancers have increased survival rates over the past few decades.
Chronic total occlusion of the heart, or CTO, refers to a complete blockage (100% occlusion) in one of the coronary arteries for more than three months.
Early in her career, neurosurgeon Aviva Abosch, MD, PhD, began receiving surprising feedback from Parkinson’s patients on whom she had operated. “They would come back to my clinic and say, ‘Thanks for your help with my tremor, but I really want to thank you for helping my sleep.'"
Pancreatic cancer is a tough disease to beat, with only 11.5% of patients surviving more than five years. But Nebraska Medicine researchers are working hard to find new ways to boost survival.
A new clinical trial is testing a certain prebiotic’s effect on shifting the composition and function of the gut microbiome in a beneficial way. Researchers aim to produce a treatment that will work alongside conventional therapies to enhance gut barrier function and reduce inflammation to prevent the recurrence of inflammatory bowel disease, or IBD.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?